Egyptian Drug Authority · Egypt
DEA-EG-2023-0014
Tier 1 · Regulator-publishedUnclassifiedAviso ao públicoStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(14) For2023
- Date issued
- Aug 2023
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Produto
- Ciprobay 500mg and 750mg tablets
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Fabricante
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Números de lote
- All batchesThe authority recalled every batch of this product, so no list was published.
- Prazos de validade
- Not published with the notice
- Action type
- Aviso ao público
- Classificação
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Falsificado
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Texto do aviso
- @egyptiandrugauthority
www.edaegypt.gov.eg
15301
تحذر هيئة الدواء المصرية من العبوات المقلدة من المستحضر التالي
حيث يمكن التفرقة ظاهرياً بين العبوات الأصلية والعبوات المقلدة
للمستحضر المذكور -وذلك بناءً على ماورد إلينا من الشركة صاحبة
المستحضر- كالآتى:
منشور
غش تجاري
Ciprobay tablet
وجميع التشغيلات الأخرى التي تتفق مع المواصفات المذكورة بالعبوة المقلدة
كما هو وارد بالمنشور.
أغسطس ٣٢٠٢
تشغيلة رقم
500 mg
471
750 mg
280
التركيز
Hikma Pharmالشركة المصنعة
Exforge HCT 5mg/160mg/12.5mg
B59ZX4 , BDPV3 , BDPW8تشغيلة رقم
Novartis Pharma S.A.Eالشركة المصنعة :شركة
egyptiandrugauthority
www.edaegypt.gov.eg
15301
في حال وجود شكوى يرجى الرجوع للصيدلي للتأكد من العبوة او الاتصال على الخط الساخن ١٠٣٥١ او
www.edaegypt.gov.egالابلاغ عبر الموقع الإلكتروني للهيئة
Ciprobay 500mg tablet
471تشغيلة رقم
Hikma Pharmالشركة المصنعة
Exforge HCT 5mg/160mg/12.5mg
B59ZX4 , BDPV3 , BDPW8تشغيلة رقم
Novartis Pharma S.A.Eالشركة المصنعة :شركة
egyptiandrugauthority
www.edaegypt.gov.eg
15301
في حال وجود شكوى يرجى الرجوع للصيدلي للتأكد من العبوة او الاتصال على الخط الساخن ١٠٣٥١ او
www.edaegypt.gov.egالابلاغ عبر الموقع الإلكتروني للهيئة
Ciprobay 500mg tablet
471تشغيلة رقم
Hikma Pharmالشركة المصنعة
القرص أقل سمكًاالقرص أكثر سمكًا
Exforge HCT 5mg/160mg/12.5mg
B59ZX4 , BDPV3 , BDPW8تشغيلة رقم
Novartis Pharma S.A.Eالشركة المصنعة :شركة
egyptiandrugauthority
www.edaegypt.gov.eg
15301
في حال وجود شكوى يرجى الرجوع للصيدلي للتأكد من العبوة او الاتصال على الخط الساخن ١٠٣٥١ او
www.edaegypt.gov.egالابلاغ عبر الموقع الإلكتروني للهيئة
Ciprobay 750mg tablet
280تشغيلة رقم
Hikma Pharmالشركة المصنعة
القرص أقل سمكًاالقرص أكثر سمكًاOriginal language: ar
- Texto do aviso em inglês
- Trade-counterfeiting circular. The Egyptian Drug Authority warns against counterfeit packs of the following product: Ciprobay tablet, together with every other batch matching the specifications given on the counterfeit pack. Genuine and counterfeit packs can be told apart by sight, on the basis of what the company that owns the product has reported to the Authority.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Estado
- Em vigor
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- f2cca748f7a3f625a3bd77e2d42f92f1e9c0db3e4b2fe9beba6f4e1d26bbfb73SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:36:59 UTC
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-XXX-2026-0003 | 03 Jul 2026 | XX | DARZALEX (daratumumab) | MYS7381 · STV1K01 | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0070 | Jul 2026 | EG | Tagrisso 80 mg film-coated tablets | FEST | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-XXX-2026-0002 | 16 Jun 2026 | XX | JAKAVI (ruxolitinib) | none published | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0062 | Jun 2026 | EG | COLOVERIN-D 30 film Coated Tablets | 251035A | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0061 | Jun 2026 | EG | FLOPADEX 8mg Hard gelatin capsules 30 | 2504626 | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0060 | Jun 2026 | EG | Tears Guard Artificial Tears & Lubricant (Sterile Ophthalmic Solution) | 0425118 | Public warning | Unclassified | Tier 1 · Regulator-published |
Cite this record
Drug Eye Africa (2023). DEA-EG-2023-0014: Ciprobay 500mg and 750mg tablets — Aviso ao público, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2023/dea-eg-2023-0014Version history
v1Manufacturer removed: the notice describes the packaging as counterfeit (correction)
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.